367 related articles for article (PubMed ID: 28078601)
41. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor-β transiently induces vimentin expression and invasive capacity in a canine mammary gland tumor cell line.
Yoshida K; Saito T; Kamida A; Matsumoto K; Saeki K; Mochizuki M; Sasaki N; Nakagawa T
Res Vet Sci; 2013 Jun; 94(3):539-41. PubMed ID: 23182613
[TBL] [Abstract][Full Text] [Related]
43. Vitamin D regulating TGF-β induced epithelial-mesenchymal transition.
Fischer KD; Agrawal DK
Respir Res; 2014 Nov; 15(1):146. PubMed ID: 25413472
[TBL] [Abstract][Full Text] [Related]
44. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
45. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
47. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
48. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
49. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
50. Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis.
Pal I; Rajesh Y; Banik P; Dey G; Dey KK; Bharti R; Naskar D; Chakraborty S; Ghosh SK; Das SK; Emdad L; Kundu SC; Fisher PB; Mandal M
Cancer Lett; 2019 Jun; 452():254-263. PubMed ID: 30904616
[TBL] [Abstract][Full Text] [Related]
51. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
52. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
54. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
Jung H; Kim B; Moon BI; Oh ES
Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
[TBL] [Abstract][Full Text] [Related]
55. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
56. 1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells.
Brito RB; Malta CS; Souza DM; Matheus LH; Matos YS; Silva CS; Ferreira JM; Nunes VS; França CM; Dellê H
PLoS One; 2015; 10(8):e0134858. PubMed ID: 26267811
[TBL] [Abstract][Full Text] [Related]
57. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
[TBL] [Abstract][Full Text] [Related]
58. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
[TBL] [Abstract][Full Text] [Related]
59. Hypaconitine inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells.
Feng HT; Zhao WW; Lu JJ; Wang YT; Chen XP
Chin J Nat Med; 2017 Jun; 15(6):427-435. PubMed ID: 28629532
[TBL] [Abstract][Full Text] [Related]
60. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
Feng H; Lu JJ; Wang Y; Pei L; Chen X
Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]